Target,Reference Ab,Method,HCDRs Designed,HCDR1,HCDR2,HCDR3,KD (nM),heavy,light,fitness
TSLP,Tezepelumab,Positive Control,,GFTFRTYG,IWYDGSNK,ARAPQWELVHEAFDI,0.1064353455,QMQLVESGGGVVQPGRSLRLSCAASGFTFRTYGMHWVRQAPGKGLEWVAVIWYDGSNKHYADSVKGRFTITRDNSKNTLNLQMNSLRAEDTAVYYCARAPQWELVHEAFDIWGQGTMVTVSS,SYVLTQPPSVSVAPGQTARITCGGNNLGSKSVHWYQQKPGQAPVLVVYDDSDRPSWIPERFSGSNSGNTATLTISRGEAGDEADYYCQVWDSSSDHVVFGGGTKLTVL,0.1064353455
TSLP,Tezepelumab,SAbDab,HCDR3,GFTFRTYG,IWYDGSNK,AREPPLFYSSWSLDN,0.2029999999999998,QMQLVESGGGVVQPGRSLRLSCAASGFTFRTYGMHWVRQAPGKGLEWVAVIWYDGSNKHYADSVKGRFTITRDNSKNTLNLQMNSLRAEDTAVYYCAREPPLFYSSWSLDNWGQGTMVTVSS,SYVLTQPPSVSVAPGQTARITCGGNNLGSKSVHWYQQKPGQAPVLVVYDDSDRPSWIPERFSGSNSGNTATLTISRGEAGDEADYYCQVWDSSSDHVVFGGGTKLTVL,0.2029999999999998
TSLP,Tezepelumab,SAbDab,HCDR3,GFTFRTYG,IWYDGSNK,ARGPFSRYDYFAMDN,557.0000000000006,QMQLVESGGGVVQPGRSLRLSCAASGFTFRTYGMHWVRQAPGKGLEWVAVIWYDGSNKHYADSVKGRFTITRDNSKNTLNLQMNSLRAEDTAVYYCARGPFSRYDYFAMDNWGQGTMVTVSS,SYVLTQPPSVSVAPGQTARITCGGNNLGSKSVHWYQQKPGQAPVLVVYDDSDRPSWIPERFSGSNSGNTATLTISRGEAGDEADYYCQVWDSSSDHVVFGGGTKLTVL,557.0000000000006
TSLP,Tezepelumab,SAbDab,HCDR3,GFTFRTYG,IWYDGSNK,ANLKDSRYSGSYYDY,522.9999999999999,QMQLVESGGGVVQPGRSLRLSCAASGFTFRTYGMHWVRQAPGKGLEWVAVIWYDGSNKHYADSVKGRFTITRDNSKNTLNLQMNSLRAEDTAVYYCANLKDSRYSGSYYDYWGQGTMVTVSS,SYVLTQPPSVSVAPGQTARITCGGNNLGSKSVHWYQQKPGQAPVLVVYDDSDRPSWIPERFSGSNSGNTATLTISRGEAGDEADYYCQVWDSSSDHVVFGGGTKLTVL,522.9999999999999
TSLP,Tezepelumab,SAbDab,HCDR3,GFTFRTYG,IWYDGSNK,VRGSITWPTEYYLDY,426.0000000000004,QMQLVESGGGVVQPGRSLRLSCAASGFTFRTYGMHWVRQAPGKGLEWVAVIWYDGSNKHYADSVKGRFTITRDNSKNTLNLQMNSLRAEDTAVYYCVRGSITWPTEYYLDYWGQGTMVTVSS,SYVLTQPPSVSVAPGQTARITCGGNNLGSKSVHWYQQKPGQAPVLVVYDDSDRPSWIPERFSGSNSGNTATLTISRGEAGDEADYYCQVWDSSSDHVVFGGGTKLTVL,426.0000000000004
TSLP,Tezepelumab,SAbDab,HCDR3,GFTFRTYG,IWYDGSNK,ARPPYYYGTTYYFDY,300.0000000000001,QMQLVESGGGVVQPGRSLRLSCAASGFTFRTYGMHWVRQAPGKGLEWVAVIWYDGSNKHYADSVKGRFTITRDNSKNTLNLQMNSLRAEDTAVYYCARPPYYYGTTYYFDYWGQGTMVTVSS,SYVLTQPPSVSVAPGQTARITCGGNNLGSKSVHWYQQKPGQAPVLVVYDDSDRPSWIPERFSGSNSGNTATLTISRGEAGDEADYYCQVWDSSSDHVVFGGGTKLTVL,300.0000000000001
TSLP,Tezepelumab,SAbDab,HCDR3,GFTFRTYG,IWYDGSNK,ARDESTGDYYYYMDV,229.0000000000002,QMQLVESGGGVVQPGRSLRLSCAASGFTFRTYGMHWVRQAPGKGLEWVAVIWYDGSNKHYADSVKGRFTITRDNSKNTLNLQMNSLRAEDTAVYYCARDESTGDYYYYMDVWGQGTMVTVSS,SYVLTQPPSVSVAPGQTARITCGGNNLGSKSVHWYQQKPGQAPVLVVYDDSDRPSWIPERFSGSNSGNTATLTISRGEAGDEADYYCQVWDSSSDHVVFGGGTKLTVL,229.0000000000002
TSLP,Tezepelumab,SAbDab,HCDR3,GFTFRTYG,IWYDGSNK,ARGPMALLYYRGFDY,183.0000000000001,QMQLVESGGGVVQPGRSLRLSCAASGFTFRTYGMHWVRQAPGKGLEWVAVIWYDGSNKHYADSVKGRFTITRDNSKNTLNLQMNSLRAEDTAVYYCARGPMALLYYRGFDYWGQGTMVTVSS,SYVLTQPPSVSVAPGQTARITCGGNNLGSKSVHWYQQKPGQAPVLVVYDDSDRPSWIPERFSGSNSGNTATLTISRGEAGDEADYYCQVWDSSSDHVVFGGGTKLTVL,183.0000000000001
TSLP,Tezepelumab,SAbDab,HCDR3,GFTFRTYG,IWYDGSNK,ARDRFDVASGSSFDF,125.99999999999989,QMQLVESGGGVVQPGRSLRLSCAASGFTFRTYGMHWVRQAPGKGLEWVAVIWYDGSNKHYADSVKGRFTITRDNSKNTLNLQMNSLRAEDTAVYYCARDRFDVASGSSFDFWGQGTMVTVSS,SYVLTQPPSVSVAPGQTARITCGGNNLGSKSVHWYQQKPGQAPVLVVYDDSDRPSWIPERFSGSNSGNTATLTISRGEAGDEADYYCQVWDSSSDHVVFGGGTKLTVL,125.99999999999989
TSLP,Tezepelumab,SAbDab,HCDR3,GFTFRTYG,IWYDGSNK,TRDGGLLFAYYAMDY,110.00000000000009,QMQLVESGGGVVQPGRSLRLSCAASGFTFRTYGMHWVRQAPGKGLEWVAVIWYDGSNKHYADSVKGRFTITRDNSKNTLNLQMNSLRAEDTAVYYCTRDGGLLFAYYAMDYWGQGTMVTVSS,SYVLTQPPSVSVAPGQTARITCGGNNLGSKSVHWYQQKPGQAPVLVVYDDSDRPSWIPERFSGSNSGNTATLTISRGEAGDEADYYCQVWDSSSDHVVFGGGTKLTVL,110.00000000000009
TSLP,Tezepelumab,SAbDab,HCDR3,GFTFRTYG,IWYDGSNK,NAAIRTTVRTSAQEY,102.99999999999996,QMQLVESGGGVVQPGRSLRLSCAASGFTFRTYGMHWVRQAPGKGLEWVAVIWYDGSNKHYADSVKGRFTITRDNSKNTLNLQMNSLRAEDTAVYYCNAAIRTTVRTSAQEYWGQGTMVTVSS,SYVLTQPPSVSVAPGQTARITCGGNNLGSKSVHWYQQKPGQAPVLVVYDDSDRPSWIPERFSGSNSGNTATLTISRGEAGDEADYYCQVWDSSSDHVVFGGGTKLTVL,102.99999999999996
TSLP,Tezepelumab,Inverse Folding,HCDR3,GFTFRTYG,IWYDGSNK,ARSPRYDYYWEAFDV,289.9999999999997,QMQLVESGGGVVQPGRSLRLSCAASGFTFRTYGMHWVRQAPGKGLEWVAVIWYDGSNKHYADSVKGRFTITRDNSKNTLNLQMNSLRAEDTAVYYCARSPRYDYYWEAFDVWGQGTMVTVSS,SYVLTQPPSVSVAPGQTARITCGGNNLGSKSVHWYQQKPGQAPVLVVYDDSDRPSWIPERFSGSNSGNTATLTISRGEAGDEADYYCQVWDSSSDHVVFGGGTKLTVL,289.9999999999997
TSLP,Tezepelumab,Inverse Folding,HCDR3,GFTFRTYG,IWYDGSNK,ARSPRYYWYYEAFDV,81.89999999999995,QMQLVESGGGVVQPGRSLRLSCAASGFTFRTYGMHWVRQAPGKGLEWVAVIWYDGSNKHYADSVKGRFTITRDNSKNTLNLQMNSLRAEDTAVYYCARSPRYYWYYEAFDVWGQGTMVTVSS,SYVLTQPPSVSVAPGQTARITCGGNNLGSKSVHWYQQKPGQAPVLVVYDDSDRPSWIPERFSGSNSGNTATLTISRGEAGDEADYYCQVWDSSSDHVVFGGGTKLTVL,81.89999999999995
TSLP,Tezepelumab,Inverse Folding,HCDR3,GFTFRTYG,IWYDGSNK,ARAPRYDYYLEAFDV,238.00000000000017,QMQLVESGGGVVQPGRSLRLSCAASGFTFRTYGMHWVRQAPGKGLEWVAVIWYDGSNKHYADSVKGRFTITRDNSKNTLNLQMNSLRAEDTAVYYCARAPRYDYYLEAFDVWGQGTMVTVSS,SYVLTQPPSVSVAPGQTARITCGGNNLGSKSVHWYQQKPGQAPVLVVYDDSDRPSWIPERFSGSNSGNTATLTISRGEAGDEADYYCQVWDSSSDHVVFGGGTKLTVL,238.00000000000017
TSLP,Tezepelumab,Inverse Folding,HCDR3,GFTFRTYG,IWYDGSNK,ARAPRYDDRWEAFDV,193.00000000000009,QMQLVESGGGVVQPGRSLRLSCAASGFTFRTYGMHWVRQAPGKGLEWVAVIWYDGSNKHYADSVKGRFTITRDNSKNTLNLQMNSLRAEDTAVYYCARAPRYDDRWEAFDVWGQGTMVTVSS,SYVLTQPPSVSVAPGQTARITCGGNNLGSKSVHWYQQKPGQAPVLVVYDDSDRPSWIPERFSGSNSGNTATLTISRGEAGDEADYYCQVWDSSSDHVVFGGGTKLTVL,193.00000000000009
TSLP,Tezepelumab,Inverse Folding,HCDR3,GFTFRTYG,IWYDGSNK,ARAPRYDTYYEAFDV,83.89999999999995,QMQLVESGGGVVQPGRSLRLSCAASGFTFRTYGMHWVRQAPGKGLEWVAVIWYDGSNKHYADSVKGRFTITRDNSKNTLNLQMNSLRAEDTAVYYCARAPRYDTYYEAFDVWGQGTMVTVSS,SYVLTQPPSVSVAPGQTARITCGGNNLGSKSVHWYQQKPGQAPVLVVYDDSDRPSWIPERFSGSNSGNTATLTISRGEAGDEADYYCQVWDSSSDHVVFGGGTKLTVL,83.89999999999995
TSLP,Tezepelumab,Inverse Folding,HCDR3,GFTFRTYG,IWYDGSNK,ARSPRYDWYWEAFDV,240.0000000000002,QMQLVESGGGVVQPGRSLRLSCAASGFTFRTYGMHWVRQAPGKGLEWVAVIWYDGSNKHYADSVKGRFTITRDNSKNTLNLQMNSLRAEDTAVYYCARSPRYDWYWEAFDVWGQGTMVTVSS,SYVLTQPPSVSVAPGQTARITCGGNNLGSKSVHWYQQKPGQAPVLVVYDDSDRPSWIPERFSGSNSGNTATLTISRGEAGDEADYYCQVWDSSSDHVVFGGGTKLTVL,240.0000000000002
TSLP,Tezepelumab,Inverse Folding,HCDR3,GFTFRTYG,IWYDGSNK,ARAPRYDWLYEAFDV,82.99999999999997,QMQLVESGGGVVQPGRSLRLSCAASGFTFRTYGMHWVRQAPGKGLEWVAVIWYDGSNKHYADSVKGRFTITRDNSKNTLNLQMNSLRAEDTAVYYCARAPRYDWLYEAFDVWGQGTMVTVSS,SYVLTQPPSVSVAPGQTARITCGGNNLGSKSVHWYQQKPGQAPVLVVYDDSDRPSWIPERFSGSNSGNTATLTISRGEAGDEADYYCQVWDSSSDHVVFGGGTKLTVL,82.99999999999997
TSLP,Tezepelumab,Inverse Folding,HCDR3,GFTFRTYG,IWYDGSNK,ARAPRYDDLYEAFDV,122.00000000000004,QMQLVESGGGVVQPGRSLRLSCAASGFTFRTYGMHWVRQAPGKGLEWVAVIWYDGSNKHYADSVKGRFTITRDNSKNTLNLQMNSLRAEDTAVYYCARAPRYDDLYEAFDVWGQGTMVTVSS,SYVLTQPPSVSVAPGQTARITCGGNNLGSKSVHWYQQKPGQAPVLVVYDDSDRPSWIPERFSGSNSGNTATLTISRGEAGDEADYYCQVWDSSSDHVVFGGGTKLTVL,122.00000000000004
TSLP,Tezepelumab,Inverse Folding,HCDR3,GFTFRTYG,IWYDGSNK,ARAPRYDDTYEAFDV,86.2,QMQLVESGGGVVQPGRSLRLSCAASGFTFRTYGMHWVRQAPGKGLEWVAVIWYDGSNKHYADSVKGRFTITRDNSKNTLNLQMNSLRAEDTAVYYCARAPRYDDTYEAFDVWGQGTMVTVSS,SYVLTQPPSVSVAPGQTARITCGGNNLGSKSVHWYQQKPGQAPVLVVYDDSDRPSWIPERFSGSNSGNTATLTISRGEAGDEADYYCQVWDSSSDHVVFGGGTKLTVL,86.2
TSLP,Tezepelumab,Inverse Folding,HCDR3,GFTFRTYG,IWYDGSNK,ARAPRYDEAYEAFDV,102.99999999999996,QMQLVESGGGVVQPGRSLRLSCAASGFTFRTYGMHWVRQAPGKGLEWVAVIWYDGSNKHYADSVKGRFTITRDNSKNTLNLQMNSLRAEDTAVYYCARAPRYDEAYEAFDVWGQGTMVTVSS,SYVLTQPPSVSVAPGQTARITCGGNNLGSKSVHWYQQKPGQAPVLVVYDDSDRPSWIPERFSGSNSGNTATLTISRGEAGDEADYYCQVWDSSSDHVVFGGGTKLTVL,102.99999999999996
TSLP,Tezepelumab,Inverse Folding,HCDR3,GFTFRTYG,IWYDGSNK,ARAPRYDDRYEAFDV,241.0,QMQLVESGGGVVQPGRSLRLSCAASGFTFRTYGMHWVRQAPGKGLEWVAVIWYDGSNKHYADSVKGRFTITRDNSKNTLNLQMNSLRAEDTAVYYCARAPRYDDRYEAFDVWGQGTMVTVSS,SYVLTQPPSVSVAPGQTARITCGGNNLGSKSVHWYQQKPGQAPVLVVYDDSDRPSWIPERFSGSNSGNTATLTISRGEAGDEADYYCQVWDSSSDHVVFGGGTKLTVL,241.0
TSLP,Tezepelumab,Inverse Folding,HCDR3,GFTFRTYG,IWYDGSNK,ARAPRYDWEYEAFDV,102.0000000000001,QMQLVESGGGVVQPGRSLRLSCAASGFTFRTYGMHWVRQAPGKGLEWVAVIWYDGSNKHYADSVKGRFTITRDNSKNTLNLQMNSLRAEDTAVYYCARAPRYDWEYEAFDVWGQGTMVTVSS,SYVLTQPPSVSVAPGQTARITCGGNNLGSKSVHWYQQKPGQAPVLVVYDDSDRPSWIPERFSGSNSGNTATLTISRGEAGDEADYYCQVWDSSSDHVVFGGGTKLTVL,102.0000000000001
TSLP,Tezepelumab,Inverse Folding,HCDR3,GFTFRTYG,IWYDGSNK,ARSPRYDDYLEAFDV,228.00000000000009,QMQLVESGGGVVQPGRSLRLSCAASGFTFRTYGMHWVRQAPGKGLEWVAVIWYDGSNKHYADSVKGRFTITRDNSKNTLNLQMNSLRAEDTAVYYCARSPRYDDYLEAFDVWGQGTMVTVSS,SYVLTQPPSVSVAPGQTARITCGGNNLGSKSVHWYQQKPGQAPVLVVYDDSDRPSWIPERFSGSNSGNTATLTISRGEAGDEADYYCQVWDSSSDHVVFGGGTKLTVL,228.00000000000009
TSLP,Tezepelumab,Inverse Folding,HCDR3,GFTFRTYG,IWYDGSNK,ARSPRYYDYWEAFDV,72.30000000000003,QMQLVESGGGVVQPGRSLRLSCAASGFTFRTYGMHWVRQAPGKGLEWVAVIWYDGSNKHYADSVKGRFTITRDNSKNTLNLQMNSLRAEDTAVYYCARSPRYYDYWEAFDVWGQGTMVTVSS,SYVLTQPPSVSVAPGQTARITCGGNNLGSKSVHWYQQKPGQAPVLVVYDDSDRPSWIPERFSGSNSGNTATLTISRGEAGDEADYYCQVWDSSSDHVVFGGGTKLTVL,72.30000000000003
TSLP,Tezepelumab,Inverse Folding,HCDR3,GFTFRTYG,IWYDGSNK,ARAPRYDYYVEAFDV,109.00000000000004,QMQLVESGGGVVQPGRSLRLSCAASGFTFRTYGMHWVRQAPGKGLEWVAVIWYDGSNKHYADSVKGRFTITRDNSKNTLNLQMNSLRAEDTAVYYCARAPRYDYYVEAFDVWGQGTMVTVSS,SYVLTQPPSVSVAPGQTARITCGGNNLGSKSVHWYQQKPGQAPVLVVYDDSDRPSWIPERFSGSNSGNTATLTISRGEAGDEADYYCQVWDSSSDHVVFGGGTKLTVL,109.00000000000004
TSLP,Tezepelumab,Inverse Folding,HCDR3,GFTFRTYG,IWYDGSNK,ARSPRYDWYLEAFDV,335.0000000000003,QMQLVESGGGVVQPGRSLRLSCAASGFTFRTYGMHWVRQAPGKGLEWVAVIWYDGSNKHYADSVKGRFTITRDNSKNTLNLQMNSLRAEDTAVYYCARSPRYDWYLEAFDVWGQGTMVTVSS,SYVLTQPPSVSVAPGQTARITCGGNNLGSKSVHWYQQKPGQAPVLVVYDDSDRPSWIPERFSGSNSGNTATLTISRGEAGDEADYYCQVWDSSSDHVVFGGGTKLTVL,335.0000000000003
TSLP,Tezepelumab,Inverse Folding,HCDR3,GFTFRTYG,IWYDGSNK,ARSPRYDEYYEAFDV,241.9999999999999,QMQLVESGGGVVQPGRSLRLSCAASGFTFRTYGMHWVRQAPGKGLEWVAVIWYDGSNKHYADSVKGRFTITRDNSKNTLNLQMNSLRAEDTAVYYCARSPRYDEYYEAFDVWGQGTMVTVSS,SYVLTQPPSVSVAPGQTARITCGGNNLGSKSVHWYQQKPGQAPVLVVYDDSDRPSWIPERFSGSNSGNTATLTISRGEAGDEADYYCQVWDSSSDHVVFGGGTKLTVL,241.9999999999999
TSLP,Tezepelumab,Inverse Folding,HCDR3,GFTFRTYG,IWYDGSNK,ARSPRYDYYYEAFDV,336.99999999999994,QMQLVESGGGVVQPGRSLRLSCAASGFTFRTYGMHWVRQAPGKGLEWVAVIWYDGSNKHYADSVKGRFTITRDNSKNTLNLQMNSLRAEDTAVYYCARSPRYDYYYEAFDVWGQGTMVTVSS,SYVLTQPPSVSVAPGQTARITCGGNNLGSKSVHWYQQKPGQAPVLVVYDDSDRPSWIPERFSGSNSGNTATLTISRGEAGDEADYYCQVWDSSSDHVVFGGGTKLTVL,336.99999999999994
TSLP,Tezepelumab,Inverse Folding,HCDR3,GFTFRTYG,IWYDGSNK,ARAPRYDEYYDAFDV,292.9999999999998,QMQLVESGGGVVQPGRSLRLSCAASGFTFRTYGMHWVRQAPGKGLEWVAVIWYDGSNKHYADSVKGRFTITRDNSKNTLNLQMNSLRAEDTAVYYCARAPRYDEYYDAFDVWGQGTMVTVSS,SYVLTQPPSVSVAPGQTARITCGGNNLGSKSVHWYQQKPGQAPVLVVYDDSDRPSWIPERFSGSNSGNTATLTISRGEAGDEADYYCQVWDSSSDHVVFGGGTKLTVL,292.9999999999998
TSLP,Tezepelumab,Inverse Folding,HCDR3,GFTFRTYG,IWYDGSNK,ARAPRYDYEYEAFDV,104.00000000000009,QMQLVESGGGVVQPGRSLRLSCAASGFTFRTYGMHWVRQAPGKGLEWVAVIWYDGSNKHYADSVKGRFTITRDNSKNTLNLQMNSLRAEDTAVYYCARAPRYDYEYEAFDVWGQGTMVTVSS,SYVLTQPPSVSVAPGQTARITCGGNNLGSKSVHWYQQKPGQAPVLVVYDDSDRPSWIPERFSGSNSGNTATLTISRGEAGDEADYYCQVWDSSSDHVVFGGGTKLTVL,104.00000000000009
TSLP,Tezepelumab,Inverse Folding,HCDR3,GFTFRTYG,IWYDGSNK,ARSPRYDEYWEAFDV,369.0000000000002,QMQLVESGGGVVQPGRSLRLSCAASGFTFRTYGMHWVRQAPGKGLEWVAVIWYDGSNKHYADSVKGRFTITRDNSKNTLNLQMNSLRAEDTAVYYCARSPRYDEYWEAFDVWGQGTMVTVSS,SYVLTQPPSVSVAPGQTARITCGGNNLGSKSVHWYQQKPGQAPVLVVYDDSDRPSWIPERFSGSNSGNTATLTISRGEAGDEADYYCQVWDSSSDHVVFGGGTKLTVL,369.0000000000002
TSLP,Tezepelumab,Inverse Folding,HCDR3,GFTFRTYG,IWYDGSNK,ARAPRYDDYLEAFDV,99.8999999999999,QMQLVESGGGVVQPGRSLRLSCAASGFTFRTYGMHWVRQAPGKGLEWVAVIWYDGSNKHYADSVKGRFTITRDNSKNTLNLQMNSLRAEDTAVYYCARAPRYDDYLEAFDVWGQGTMVTVSS,SYVLTQPPSVSVAPGQTARITCGGNNLGSKSVHWYQQKPGQAPVLVVYDDSDRPSWIPERFSGSNSGNTATLTISRGEAGDEADYYCQVWDSSSDHVVFGGGTKLTVL,99.8999999999999
TSLP,Tezepelumab,Inverse Folding,HCDR3,GFTFRTYG,IWYDGSNK,ARAPRYDFYYEAFDV,115.99999999999991,QMQLVESGGGVVQPGRSLRLSCAASGFTFRTYGMHWVRQAPGKGLEWVAVIWYDGSNKHYADSVKGRFTITRDNSKNTLNLQMNSLRAEDTAVYYCARAPRYDFYYEAFDVWGQGTMVTVSS,SYVLTQPPSVSVAPGQTARITCGGNNLGSKSVHWYQQKPGQAPVLVVYDDSDRPSWIPERFSGSNSGNTATLTISRGEAGDEADYYCQVWDSSSDHVVFGGGTKLTVL,115.99999999999991
TSLP,Tezepelumab,Inverse Folding,HCDR3,GFTFRTYG,IWYDGSNK,ARAPRYDWAYEAFDV,403.9999999999998,QMQLVESGGGVVQPGRSLRLSCAASGFTFRTYGMHWVRQAPGKGLEWVAVIWYDGSNKHYADSVKGRFTITRDNSKNTLNLQMNSLRAEDTAVYYCARAPRYDWAYEAFDVWGQGTMVTVSS,SYVLTQPPSVSVAPGQTARITCGGNNLGSKSVHWYQQKPGQAPVLVVYDDSDRPSWIPERFSGSNSGNTATLTISRGEAGDEADYYCQVWDSSSDHVVFGGGTKLTVL,403.9999999999998
TSLP,Tezepelumab,Inverse Folding,HCDR3,GFTFRTYG,IWYDGSNK,ARAPRYDDAYEAFDV,99.60000000000002,QMQLVESGGGVVQPGRSLRLSCAASGFTFRTYGMHWVRQAPGKGLEWVAVIWYDGSNKHYADSVKGRFTITRDNSKNTLNLQMNSLRAEDTAVYYCARAPRYDDAYEAFDVWGQGTMVTVSS,SYVLTQPPSVSVAPGQTARITCGGNNLGSKSVHWYQQKPGQAPVLVVYDDSDRPSWIPERFSGSNSGNTATLTISRGEAGDEADYYCQVWDSSSDHVVFGGGTKLTVL,99.60000000000002
TSLP,Tezepelumab,Inverse Folding,HCDR3,GFTFRTYG,IWYDGSNK,ARAPRYDERWEAFDV,494.00000000000017,QMQLVESGGGVVQPGRSLRLSCAASGFTFRTYGMHWVRQAPGKGLEWVAVIWYDGSNKHYADSVKGRFTITRDNSKNTLNLQMNSLRAEDTAVYYCARAPRYDERWEAFDVWGQGTMVTVSS,SYVLTQPPSVSVAPGQTARITCGGNNLGSKSVHWYQQKPGQAPVLVVYDDSDRPSWIPERFSGSNSGNTATLTISRGEAGDEADYYCQVWDSSSDHVVFGGGTKLTVL,494.00000000000017
TSLP,Tezepelumab,Inverse Folding,HCDR3,GFTFRTYG,IWYDGSNK,ARAPRYDDDWEAFDV,82.70000000000007,QMQLVESGGGVVQPGRSLRLSCAASGFTFRTYGMHWVRQAPGKGLEWVAVIWYDGSNKHYADSVKGRFTITRDNSKNTLNLQMNSLRAEDTAVYYCARAPRYDDDWEAFDVWGQGTMVTVSS,SYVLTQPPSVSVAPGQTARITCGGNNLGSKSVHWYQQKPGQAPVLVVYDDSDRPSWIPERFSGSNSGNTATLTISRGEAGDEADYYCQVWDSSSDHVVFGGGTKLTVL,82.70000000000007
TSLP,Tezepelumab,Inverse Folding,HCDR3,GFTFRTYG,IWYDGSNK,ARAPRYDEYWEAFDV,84.89999999999993,QMQLVESGGGVVQPGRSLRLSCAASGFTFRTYGMHWVRQAPGKGLEWVAVIWYDGSNKHYADSVKGRFTITRDNSKNTLNLQMNSLRAEDTAVYYCARAPRYDEYWEAFDVWGQGTMVTVSS,SYVLTQPPSVSVAPGQTARITCGGNNLGSKSVHWYQQKPGQAPVLVVYDDSDRPSWIPERFSGSNSGNTATLTISRGEAGDEADYYCQVWDSSSDHVVFGGGTKLTVL,84.89999999999993
TSLP,Tezepelumab,Inverse Folding,HCDR3,GFTFRTYG,IWYDGSNK,ARAPRYDEHYEAFDV,168.00000000000017,QMQLVESGGGVVQPGRSLRLSCAASGFTFRTYGMHWVRQAPGKGLEWVAVIWYDGSNKHYADSVKGRFTITRDNSKNTLNLQMNSLRAEDTAVYYCARAPRYDEHYEAFDVWGQGTMVTVSS,SYVLTQPPSVSVAPGQTARITCGGNNLGSKSVHWYQQKPGQAPVLVVYDDSDRPSWIPERFSGSNSGNTATLTISRGEAGDEADYYCQVWDSSSDHVVFGGGTKLTVL,168.00000000000017
TSLP,Tezepelumab,Inverse Folding,HCDR3,GFTFRTYG,IWYDGSNK,ARAPRYYWYWEAFDV,23.599999999999984,QMQLVESGGGVVQPGRSLRLSCAASGFTFRTYGMHWVRQAPGKGLEWVAVIWYDGSNKHYADSVKGRFTITRDNSKNTLNLQMNSLRAEDTAVYYCARAPRYYWYWEAFDVWGQGTMVTVSS,SYVLTQPPSVSVAPGQTARITCGGNNLGSKSVHWYQQKPGQAPVLVVYDDSDRPSWIPERFSGSNSGNTATLTISRGEAGDEADYYCQVWDSSSDHVVFGGGTKLTVL,23.599999999999984
TSLP,Tezepelumab,Inverse Folding,HCDR3,GFTFRTYG,IWYDGSNK,ARAPRYDWTYEAFDV,128.0000000000001,QMQLVESGGGVVQPGRSLRLSCAASGFTFRTYGMHWVRQAPGKGLEWVAVIWYDGSNKHYADSVKGRFTITRDNSKNTLNLQMNSLRAEDTAVYYCARAPRYDWTYEAFDVWGQGTMVTVSS,SYVLTQPPSVSVAPGQTARITCGGNNLGSKSVHWYQQKPGQAPVLVVYDDSDRPSWIPERFSGSNSGNTATLTISRGEAGDEADYYCQVWDSSSDHVVFGGGTKLTVL,128.0000000000001
TSLP,Tezepelumab,Inverse Folding,HCDR3,GFTFRTYG,IWYDGSNK,ARAPRYYEYWEAFDV,29.200000000000006,QMQLVESGGGVVQPGRSLRLSCAASGFTFRTYGMHWVRQAPGKGLEWVAVIWYDGSNKHYADSVKGRFTITRDNSKNTLNLQMNSLRAEDTAVYYCARAPRYYEYWEAFDVWGQGTMVTVSS,SYVLTQPPSVSVAPGQTARITCGGNNLGSKSVHWYQQKPGQAPVLVVYDDSDRPSWIPERFSGSNSGNTATLTISRGEAGDEADYYCQVWDSSSDHVVFGGGTKLTVL,29.200000000000006
TSLP,Tezepelumab,Inverse Folding,HCDR3,GFTFRTYG,IWYDGSNK,ARAPRYDYYYEAFDV,138.00000000000014,QMQLVESGGGVVQPGRSLRLSCAASGFTFRTYGMHWVRQAPGKGLEWVAVIWYDGSNKHYADSVKGRFTITRDNSKNTLNLQMNSLRAEDTAVYYCARAPRYDYYYEAFDVWGQGTMVTVSS,SYVLTQPPSVSVAPGQTARITCGGNNLGSKSVHWYQQKPGQAPVLVVYDDSDRPSWIPERFSGSNSGNTATLTISRGEAGDEADYYCQVWDSSSDHVVFGGGTKLTVL,138.00000000000014
TSLP,Tezepelumab,Inverse Folding,HCDR3,GFTFRTYG,IWYDGSNK,ARSPRYDWYYEAFDV,122.00000000000004,QMQLVESGGGVVQPGRSLRLSCAASGFTFRTYGMHWVRQAPGKGLEWVAVIWYDGSNKHYADSVKGRFTITRDNSKNTLNLQMNSLRAEDTAVYYCARSPRYDWYYEAFDVWGQGTMVTVSS,SYVLTQPPSVSVAPGQTARITCGGNNLGSKSVHWYQQKPGQAPVLVVYDDSDRPSWIPERFSGSNSGNTATLTISRGEAGDEADYYCQVWDSSSDHVVFGGGTKLTVL,122.00000000000004
TSLP,Tezepelumab,Inverse Folding,HCDR3,GFTFRTYG,IWYDGSNK,ARAPRYYDYLEAFDV,22.600000000000016,QMQLVESGGGVVQPGRSLRLSCAASGFTFRTYGMHWVRQAPGKGLEWVAVIWYDGSNKHYADSVKGRFTITRDNSKNTLNLQMNSLRAEDTAVYYCARAPRYYDYLEAFDVWGQGTMVTVSS,SYVLTQPPSVSVAPGQTARITCGGNNLGSKSVHWYQQKPGQAPVLVVYDDSDRPSWIPERFSGSNSGNTATLTISRGEAGDEADYYCQVWDSSSDHVVFGGGTKLTVL,22.600000000000016
TSLP,Tezepelumab,Inverse Folding,HCDR3,GFTFRTYG,IWYDGSNK,ARAPRYYEAYEAFDV,31.00000000000003,QMQLVESGGGVVQPGRSLRLSCAASGFTFRTYGMHWVRQAPGKGLEWVAVIWYDGSNKHYADSVKGRFTITRDNSKNTLNLQMNSLRAEDTAVYYCARAPRYYEAYEAFDVWGQGTMVTVSS,SYVLTQPPSVSVAPGQTARITCGGNNLGSKSVHWYQQKPGQAPVLVVYDDSDRPSWIPERFSGSNSGNTATLTISRGEAGDEADYYCQVWDSSSDHVVFGGGTKLTVL,31.00000000000003
TSLP,Tezepelumab,Inverse Folding,HCDR3,GFTFRTYG,IWYDGSNK,ARAPRYDETWEAFDV,140.99999999999991,QMQLVESGGGVVQPGRSLRLSCAASGFTFRTYGMHWVRQAPGKGLEWVAVIWYDGSNKHYADSVKGRFTITRDNSKNTLNLQMNSLRAEDTAVYYCARAPRYDETWEAFDVWGQGTMVTVSS,SYVLTQPPSVSVAPGQTARITCGGNNLGSKSVHWYQQKPGQAPVLVVYDDSDRPSWIPERFSGSNSGNTATLTISRGEAGDEADYYCQVWDSSSDHVVFGGGTKLTVL,140.99999999999991
TSLP,Tezepelumab,Inverse Folding,HCDR3,GFTFRTYG,IWYDGSNK,ARAPRYYEYLEAFDV,31.89999999999999,QMQLVESGGGVVQPGRSLRLSCAASGFTFRTYGMHWVRQAPGKGLEWVAVIWYDGSNKHYADSVKGRFTITRDNSKNTLNLQMNSLRAEDTAVYYCARAPRYYEYLEAFDVWGQGTMVTVSS,SYVLTQPPSVSVAPGQTARITCGGNNLGSKSVHWYQQKPGQAPVLVVYDDSDRPSWIPERFSGSNSGNTATLTISRGEAGDEADYYCQVWDSSSDHVVFGGGTKLTVL,31.89999999999999
TSLP,Tezepelumab,Inverse Folding,HCDR3,GFTFRTYG,IWYDGSNK,ARAPRYDEEYEAFDV,78.90000000000006,QMQLVESGGGVVQPGRSLRLSCAASGFTFRTYGMHWVRQAPGKGLEWVAVIWYDGSNKHYADSVKGRFTITRDNSKNTLNLQMNSLRAEDTAVYYCARAPRYDEEYEAFDVWGQGTMVTVSS,SYVLTQPPSVSVAPGQTARITCGGNNLGSKSVHWYQQKPGQAPVLVVYDDSDRPSWIPERFSGSNSGNTATLTISRGEAGDEADYYCQVWDSSSDHVVFGGGTKLTVL,78.90000000000006
TSLP,Tezepelumab,Inverse Folding,HCDR3,GFTFRTYG,IWYDGSNK,ARAPRYDWYYEAFDV,48.2,QMQLVESGGGVVQPGRSLRLSCAASGFTFRTYGMHWVRQAPGKGLEWVAVIWYDGSNKHYADSVKGRFTITRDNSKNTLNLQMNSLRAEDTAVYYCARAPRYDWYYEAFDVWGQGTMVTVSS,SYVLTQPPSVSVAPGQTARITCGGNNLGSKSVHWYQQKPGQAPVLVVYDDSDRPSWIPERFSGSNSGNTATLTISRGEAGDEADYYCQVWDSSSDHVVFGGGTKLTVL,48.2
TSLP,Tezepelumab,Inverse Folding,HCDR3,GFTFRTYG,IWYDGSNK,ARAPRYYDYYEAFDV,33.2,QMQLVESGGGVVQPGRSLRLSCAASGFTFRTYGMHWVRQAPGKGLEWVAVIWYDGSNKHYADSVKGRFTITRDNSKNTLNLQMNSLRAEDTAVYYCARAPRYYDYYEAFDVWGQGTMVTVSS,SYVLTQPPSVSVAPGQTARITCGGNNLGSKSVHWYQQKPGQAPVLVVYDDSDRPSWIPERFSGSNSGNTATLTISRGEAGDEADYYCQVWDSSSDHVVFGGGTKLTVL,33.2
TSLP,Tezepelumab,Inverse Folding,HCDR3,GFTFRTYG,IWYDGSNK,ARAPRYDDYYDAFDV,163.0000000000001,QMQLVESGGGVVQPGRSLRLSCAASGFTFRTYGMHWVRQAPGKGLEWVAVIWYDGSNKHYADSVKGRFTITRDNSKNTLNLQMNSLRAEDTAVYYCARAPRYDDYYDAFDVWGQGTMVTVSS,SYVLTQPPSVSVAPGQTARITCGGNNLGSKSVHWYQQKPGQAPVLVVYDDSDRPSWIPERFSGSNSGNTATLTISRGEAGDEADYYCQVWDSSSDHVVFGGGTKLTVL,163.0000000000001
TSLP,Tezepelumab,Inverse Folding,HCDR3,GFTFRTYG,IWYDGSNK,ARAPRYDWYVEAFDV,54.19999999999997,QMQLVESGGGVVQPGRSLRLSCAASGFTFRTYGMHWVRQAPGKGLEWVAVIWYDGSNKHYADSVKGRFTITRDNSKNTLNLQMNSLRAEDTAVYYCARAPRYDWYVEAFDVWGQGTMVTVSS,SYVLTQPPSVSVAPGQTARITCGGNNLGSKSVHWYQQKPGQAPVLVVYDDSDRPSWIPERFSGSNSGNTATLTISRGEAGDEADYYCQVWDSSSDHVVFGGGTKLTVL,54.19999999999997
TSLP,Tezepelumab,Inverse Folding,HCDR3,GFTFRTYG,IWYDGSNK,ARAPRYDYYWEAFDV,175.0,QMQLVESGGGVVQPGRSLRLSCAASGFTFRTYGMHWVRQAPGKGLEWVAVIWYDGSNKHYADSVKGRFTITRDNSKNTLNLQMNSLRAEDTAVYYCARAPRYDYYWEAFDVWGQGTMVTVSS,SYVLTQPPSVSVAPGQTARITCGGNNLGSKSVHWYQQKPGQAPVLVVYDDSDRPSWIPERFSGSNSGNTATLTISRGEAGDEADYYCQVWDSSSDHVVFGGGTKLTVL,175.0
TSLP,Tezepelumab,Inverse Folding,HCDR3,GFTFRTYG,IWYDGSNK,ARAPRYYDAYEAFDV,33.50000000000003,QMQLVESGGGVVQPGRSLRLSCAASGFTFRTYGMHWVRQAPGKGLEWVAVIWYDGSNKHYADSVKGRFTITRDNSKNTLNLQMNSLRAEDTAVYYCARAPRYYDAYEAFDVWGQGTMVTVSS,SYVLTQPPSVSVAPGQTARITCGGNNLGSKSVHWYQQKPGQAPVLVVYDDSDRPSWIPERFSGSNSGNTATLTISRGEAGDEADYYCQVWDSSSDHVVFGGGTKLTVL,33.50000000000003
TSLP,Tezepelumab,Inverse Folding,HCDR3,GFTFRTYG,IWYDGSNK,ARSPRYDDYYEAFDV,185.9999999999999,QMQLVESGGGVVQPGRSLRLSCAASGFTFRTYGMHWVRQAPGKGLEWVAVIWYDGSNKHYADSVKGRFTITRDNSKNTLNLQMNSLRAEDTAVYYCARSPRYDDYYEAFDVWGQGTMVTVSS,SYVLTQPPSVSVAPGQTARITCGGNNLGSKSVHWYQQKPGQAPVLVVYDDSDRPSWIPERFSGSNSGNTATLTISRGEAGDEADYYCQVWDSSSDHVVFGGGTKLTVL,185.9999999999999
TSLP,Tezepelumab,Inverse Folding,HCDR3,GFTFRTYG,IWYDGSNK,ARAPRYDEHWEAFDV,170.00000000000006,QMQLVESGGGVVQPGRSLRLSCAASGFTFRTYGMHWVRQAPGKGLEWVAVIWYDGSNKHYADSVKGRFTITRDNSKNTLNLQMNSLRAEDTAVYYCARAPRYDEHWEAFDVWGQGTMVTVSS,SYVLTQPPSVSVAPGQTARITCGGNNLGSKSVHWYQQKPGQAPVLVVYDDSDRPSWIPERFSGSNSGNTATLTISRGEAGDEADYYCQVWDSSSDHVVFGGGTKLTVL,170.00000000000006
TSLP,Tezepelumab,Inverse Folding,HCDR3,GFTFRTYG,IWYDGSNK,ARSPRYDDYWEAFDV,197.0000000000002,QMQLVESGGGVVQPGRSLRLSCAASGFTFRTYGMHWVRQAPGKGLEWVAVIWYDGSNKHYADSVKGRFTITRDNSKNTLNLQMNSLRAEDTAVYYCARSPRYDDYWEAFDVWGQGTMVTVSS,SYVLTQPPSVSVAPGQTARITCGGNNLGSKSVHWYQQKPGQAPVLVVYDDSDRPSWIPERFSGSNSGNTATLTISRGEAGDEADYYCQVWDSSSDHVVFGGGTKLTVL,197.0000000000002
TSLP,Tezepelumab,Inverse Folding,HCDR3,GFTFRTYG,IWYDGSNK,ARAPRYDEYLEAFDV,128.99999999999994,QMQLVESGGGVVQPGRSLRLSCAASGFTFRTYGMHWVRQAPGKGLEWVAVIWYDGSNKHYADSVKGRFTITRDNSKNTLNLQMNSLRAEDTAVYYCARAPRYDEYLEAFDVWGQGTMVTVSS,SYVLTQPPSVSVAPGQTARITCGGNNLGSKSVHWYQQKPGQAPVLVVYDDSDRPSWIPERFSGSNSGNTATLTISRGEAGDEADYYCQVWDSSSDHVVFGGGTKLTVL,128.99999999999994
TSLP,Tezepelumab,Inverse Folding,HCDR3,GFTFRTYG,IWYDGSNK,ARAPRYDDLWEAFDV,61.09999999999997,QMQLVESGGGVVQPGRSLRLSCAASGFTFRTYGMHWVRQAPGKGLEWVAVIWYDGSNKHYADSVKGRFTITRDNSKNTLNLQMNSLRAEDTAVYYCARAPRYDDLWEAFDVWGQGTMVTVSS,SYVLTQPPSVSVAPGQTARITCGGNNLGSKSVHWYQQKPGQAPVLVVYDDSDRPSWIPERFSGSNSGNTATLTISRGEAGDEADYYCQVWDSSSDHVVFGGGTKLTVL,61.09999999999997
TSLP,Tezepelumab,Inverse Folding,HCDR3,GFTFRTYG,IWYDGSNK,ARAPRYDDYVEAFDV,44.6,QMQLVESGGGVVQPGRSLRLSCAASGFTFRTYGMHWVRQAPGKGLEWVAVIWYDGSNKHYADSVKGRFTITRDNSKNTLNLQMNSLRAEDTAVYYCARAPRYDDYVEAFDVWGQGTMVTVSS,SYVLTQPPSVSVAPGQTARITCGGNNLGSKSVHWYQQKPGQAPVLVVYDDSDRPSWIPERFSGSNSGNTATLTISRGEAGDEADYYCQVWDSSSDHVVFGGGTKLTVL,44.6
TSLP,Tezepelumab,Inverse Folding,HCDR3,GFTFRTYG,IWYDGSNK,ARAPRYYYYYEAFDV,52.29999999999999,QMQLVESGGGVVQPGRSLRLSCAASGFTFRTYGMHWVRQAPGKGLEWVAVIWYDGSNKHYADSVKGRFTITRDNSKNTLNLQMNSLRAEDTAVYYCARAPRYYYYYEAFDVWGQGTMVTVSS,SYVLTQPPSVSVAPGQTARITCGGNNLGSKSVHWYQQKPGQAPVLVVYDDSDRPSWIPERFSGSNSGNTATLTISRGEAGDEADYYCQVWDSSSDHVVFGGGTKLTVL,52.29999999999999
TSLP,Tezepelumab,Inverse Folding,HCDR123,GFTFSTYA,IWYDGSNK,ARAPRYDDYWEAFDV,717.9999999999997,QMQLVESGGGVVQPGRSLRLSCAASGFTFSTYAMHWVRQAPGKGLEWVAVIWYDGSNKHYADSVKGRFTITRDNSKNTLNLQMNSLRAEDTAVYYCARAPRYDDYWEAFDVWGQGTMVTVSS,SYVLTQPPSVSVAPGQTARITCGGNNLGSKSVHWYQQKPGQAPVLVVYDDSDRPSWIPERFSGSNSGNTATLTISRGEAGDEADYYCQVWDSSSDHVVFGGGTKLTVL,717.9999999999997
TSLP,Tezepelumab,Inverse Folding,HCDR123,GFTFSTFA,IWYDGSNK,ARAPRYDWYYEAFDV,90.79999999999998,QMQLVESGGGVVQPGRSLRLSCAASGFTFSTFAMHWVRQAPGKGLEWVAVIWYDGSNKHYADSVKGRFTITRDNSKNTLNLQMNSLRAEDTAVYYCARAPRYDWYYEAFDVWGQGTMVTVSS,SYVLTQPPSVSVAPGQTARITCGGNNLGSKSVHWYQQKPGQAPVLVVYDDSDRPSWIPERFSGSNSGNTATLTISRGEAGDEADYYCQVWDSSSDHVVFGGGTKLTVL,90.79999999999998
TSLP,Tezepelumab,Inverse Folding,HCDR123,GFTFSTYA,IWYDGSNK,ARAPRYDEYWEAFDV,632.9999999999995,QMQLVESGGGVVQPGRSLRLSCAASGFTFSTYAMHWVRQAPGKGLEWVAVIWYDGSNKHYADSVKGRFTITRDNSKNTLNLQMNSLRAEDTAVYYCARAPRYDEYWEAFDVWGQGTMVTVSS,SYVLTQPPSVSVAPGQTARITCGGNNLGSKSVHWYQQKPGQAPVLVVYDDSDRPSWIPERFSGSNSGNTATLTISRGEAGDEADYYCQVWDSSSDHVVFGGGTKLTVL,632.9999999999995
TSLP,Tezepelumab,Inverse Folding,HCDR123,GFTFSTFA,IWYDGSNK,ARAPRYDERYEAFDV,366.0000000000003,QMQLVESGGGVVQPGRSLRLSCAASGFTFSTFAMHWVRQAPGKGLEWVAVIWYDGSNKHYADSVKGRFTITRDNSKNTLNLQMNSLRAEDTAVYYCARAPRYDERYEAFDVWGQGTMVTVSS,SYVLTQPPSVSVAPGQTARITCGGNNLGSKSVHWYQQKPGQAPVLVVYDDSDRPSWIPERFSGSNSGNTATLTISRGEAGDEADYYCQVWDSSSDHVVFGGGTKLTVL,366.0000000000003
TSLP,Tezepelumab,Inverse Folding,HCDR123,GFTFSTFA,IWYDGSNK,ARAPRYYWYYEAFDV,96.59999999999992,QMQLVESGGGVVQPGRSLRLSCAASGFTFSTFAMHWVRQAPGKGLEWVAVIWYDGSNKHYADSVKGRFTITRDNSKNTLNLQMNSLRAEDTAVYYCARAPRYYWYYEAFDVWGQGTMVTVSS,SYVLTQPPSVSVAPGQTARITCGGNNLGSKSVHWYQQKPGQAPVLVVYDDSDRPSWIPERFSGSNSGNTATLTISRGEAGDEADYYCQVWDSSSDHVVFGGGTKLTVL,96.59999999999992
TSLP,Tezepelumab,Inverse Folding,HCDR123,GFTFSTYA,IWYDGSNK,ARAPRYDERYEAFDV,686.0000000000006,QMQLVESGGGVVQPGRSLRLSCAASGFTFSTYAMHWVRQAPGKGLEWVAVIWYDGSNKHYADSVKGRFTITRDNSKNTLNLQMNSLRAEDTAVYYCARAPRYDERYEAFDVWGQGTMVTVSS,SYVLTQPPSVSVAPGQTARITCGGNNLGSKSVHWYQQKPGQAPVLVVYDDSDRPSWIPERFSGSNSGNTATLTISRGEAGDEADYYCQVWDSSSDHVVFGGGTKLTVL,686.0000000000006
TSLP,Tezepelumab,Inverse Folding,HCDR123,GFTFSTYA,IWYDGSNK,ARAPRYDWYWEAFDV,758.9999999999997,QMQLVESGGGVVQPGRSLRLSCAASGFTFSTYAMHWVRQAPGKGLEWVAVIWYDGSNKHYADSVKGRFTITRDNSKNTLNLQMNSLRAEDTAVYYCARAPRYDWYWEAFDVWGQGTMVTVSS,SYVLTQPPSVSVAPGQTARITCGGNNLGSKSVHWYQQKPGQAPVLVVYDDSDRPSWIPERFSGSNSGNTATLTISRGEAGDEADYYCQVWDSSSDHVVFGGGTKLTVL,758.9999999999997
TSLP,Tezepelumab,Inverse Folding,HCDR123,GFTFSTFA,IWYDGSNK,ARSPRYYEYYEAFDV,44.50000000000004,QMQLVESGGGVVQPGRSLRLSCAASGFTFSTFAMHWVRQAPGKGLEWVAVIWYDGSNKHYADSVKGRFTITRDNSKNTLNLQMNSLRAEDTAVYYCARSPRYYEYYEAFDVWGQGTMVTVSS,SYVLTQPPSVSVAPGQTARITCGGNNLGSKSVHWYQQKPGQAPVLVVYDDSDRPSWIPERFSGSNSGNTATLTISRGEAGDEADYYCQVWDSSSDHVVFGGGTKLTVL,44.50000000000004
TSLP,Tezepelumab,Inverse Folding,HCDR123,GFTFSTFA,IWYDGSNK,ARAPRYYDYLEAFDV,62.59999999999999,QMQLVESGGGVVQPGRSLRLSCAASGFTFSTFAMHWVRQAPGKGLEWVAVIWYDGSNKHYADSVKGRFTITRDNSKNTLNLQMNSLRAEDTAVYYCARAPRYYDYLEAFDVWGQGTMVTVSS,SYVLTQPPSVSVAPGQTARITCGGNNLGSKSVHWYQQKPGQAPVLVVYDDSDRPSWIPERFSGSNSGNTATLTISRGEAGDEADYYCQVWDSSSDHVVFGGGTKLTVL,62.59999999999999
TSLP,Tezepelumab,Inverse Folding,HCDR123,GFTFSTFA,IWYDGSNK,ARAPRYDEDWEAFDV,894.0000000000005,QMQLVESGGGVVQPGRSLRLSCAASGFTFSTFAMHWVRQAPGKGLEWVAVIWYDGSNKHYADSVKGRFTITRDNSKNTLNLQMNSLRAEDTAVYYCARAPRYDEDWEAFDVWGQGTMVTVSS,SYVLTQPPSVSVAPGQTARITCGGNNLGSKSVHWYQQKPGQAPVLVVYDDSDRPSWIPERFSGSNSGNTATLTISRGEAGDEADYYCQVWDSSSDHVVFGGGTKLTVL,894.0000000000005
TSLP,Tezepelumab,Inverse Folding,HCDR123,GFTFSTYA,IWYDGSNK,ARSPRYDEYWEAFDV,836.0000000000007,QMQLVESGGGVVQPGRSLRLSCAASGFTFSTYAMHWVRQAPGKGLEWVAVIWYDGSNKHYADSVKGRFTITRDNSKNTLNLQMNSLRAEDTAVYYCARSPRYDEYWEAFDVWGQGTMVTVSS,SYVLTQPPSVSVAPGQTARITCGGNNLGSKSVHWYQQKPGQAPVLVVYDDSDRPSWIPERFSGSNSGNTATLTISRGEAGDEADYYCQVWDSSSDHVVFGGGTKLTVL,836.0000000000007
TSLP,Tezepelumab,Inverse Folding,HCDR123,GFTFSTFA,IWYDGSNK,ARAPRYYDYYEAFDV,56.80000000000005,QMQLVESGGGVVQPGRSLRLSCAASGFTFSTFAMHWVRQAPGKGLEWVAVIWYDGSNKHYADSVKGRFTITRDNSKNTLNLQMNSLRAEDTAVYYCARAPRYYDYYEAFDVWGQGTMVTVSS,SYVLTQPPSVSVAPGQTARITCGGNNLGSKSVHWYQQKPGQAPVLVVYDDSDRPSWIPERFSGSNSGNTATLTISRGEAGDEADYYCQVWDSSSDHVVFGGGTKLTVL,56.80000000000005
TSLP,Tezepelumab,Inverse Folding,HCDR123,GFTFSTYA,IWYDGSNK,ARAPRYYWYYEAFDV,87.09999999999995,QMQLVESGGGVVQPGRSLRLSCAASGFTFSTYAMHWVRQAPGKGLEWVAVIWYDGSNKHYADSVKGRFTITRDNSKNTLNLQMNSLRAEDTAVYYCARAPRYYWYYEAFDVWGQGTMVTVSS,SYVLTQPPSVSVAPGQTARITCGGNNLGSKSVHWYQQKPGQAPVLVVYDDSDRPSWIPERFSGSNSGNTATLTISRGEAGDEADYYCQVWDSSSDHVVFGGGTKLTVL,87.09999999999995
TSLP,Tezepelumab,Inverse Folding,HCDR123,GFTFSTFA,IWYDGSNK,ARSPRYDDYLEAFDV,80.50000000000004,QMQLVESGGGVVQPGRSLRLSCAASGFTFSTFAMHWVRQAPGKGLEWVAVIWYDGSNKHYADSVKGRFTITRDNSKNTLNLQMNSLRAEDTAVYYCARSPRYDDYLEAFDVWGQGTMVTVSS,SYVLTQPPSVSVAPGQTARITCGGNNLGSKSVHWYQQKPGQAPVLVVYDDSDRPSWIPERFSGSNSGNTATLTISRGEAGDEADYYCQVWDSSSDHVVFGGGTKLTVL,80.50000000000004
TSLP,Tezepelumab,Inverse Folding,HCDR123,GFTFSTFA,IWYDGSNK,ARAPRYDDYYEAFDV,92.49999999999996,QMQLVESGGGVVQPGRSLRLSCAASGFTFSTFAMHWVRQAPGKGLEWVAVIWYDGSNKHYADSVKGRFTITRDNSKNTLNLQMNSLRAEDTAVYYCARAPRYDDYYEAFDVWGQGTMVTVSS,SYVLTQPPSVSVAPGQTARITCGGNNLGSKSVHWYQQKPGQAPVLVVYDDSDRPSWIPERFSGSNSGNTATLTISRGEAGDEADYYCQVWDSSSDHVVFGGGTKLTVL,92.49999999999996
TSLP,Tezepelumab,Inverse Folding,HCDR123,GFTFSTFA,IWYDGSNK,ARSPRYYDYYEAFDV,41.800000000000026,QMQLVESGGGVVQPGRSLRLSCAASGFTFSTFAMHWVRQAPGKGLEWVAVIWYDGSNKHYADSVKGRFTITRDNSKNTLNLQMNSLRAEDTAVYYCARSPRYYDYYEAFDVWGQGTMVTVSS,SYVLTQPPSVSVAPGQTARITCGGNNLGSKSVHWYQQKPGQAPVLVVYDDSDRPSWIPERFSGSNSGNTATLTISRGEAGDEADYYCQVWDSSSDHVVFGGGTKLTVL,41.800000000000026
TSLP,Tezepelumab,Inverse Folding,HCDR123,GFTFSTYA,IWYDGSNK,ARSPRYYEYYEAFDV,57.00000000000001,QMQLVESGGGVVQPGRSLRLSCAASGFTFSTYAMHWVRQAPGKGLEWVAVIWYDGSNKHYADSVKGRFTITRDNSKNTLNLQMNSLRAEDTAVYYCARSPRYYEYYEAFDVWGQGTMVTVSS,SYVLTQPPSVSVAPGQTARITCGGNNLGSKSVHWYQQKPGQAPVLVVYDDSDRPSWIPERFSGSNSGNTATLTISRGEAGDEADYYCQVWDSSSDHVVFGGGTKLTVL,57.00000000000001
TSLP,Tezepelumab,Inverse Folding,HCDR123,GFTFSTFA,IWYDGSNK,ARAPRYYEYYEAFDV,106.00000000000004,QMQLVESGGGVVQPGRSLRLSCAASGFTFSTFAMHWVRQAPGKGLEWVAVIWYDGSNKHYADSVKGRFTITRDNSKNTLNLQMNSLRAEDTAVYYCARAPRYYEYYEAFDVWGQGTMVTVSS,SYVLTQPPSVSVAPGQTARITCGGNNLGSKSVHWYQQKPGQAPVLVVYDDSDRPSWIPERFSGSNSGNTATLTISRGEAGDEADYYCQVWDSSSDHVVFGGGTKLTVL,106.00000000000004
TSLP,Tezepelumab,Inverse Folding,HCDR123,GFTFSTFA,IWYDGSNK,ARAPRYDEHYEAFDV,777.0000000000005,QMQLVESGGGVVQPGRSLRLSCAASGFTFSTFAMHWVRQAPGKGLEWVAVIWYDGSNKHYADSVKGRFTITRDNSKNTLNLQMNSLRAEDTAVYYCARAPRYDEHYEAFDVWGQGTMVTVSS,SYVLTQPPSVSVAPGQTARITCGGNNLGSKSVHWYQQKPGQAPVLVVYDDSDRPSWIPERFSGSNSGNTATLTISRGEAGDEADYYCQVWDSSSDHVVFGGGTKLTVL,777.0000000000005
TSLP,Tezepelumab,Inverse Folding,HCDR123,GFTFSTFA,IWYDGSNK,ARAPRYDDDYEAFDV,112.00000000000009,QMQLVESGGGVVQPGRSLRLSCAASGFTFSTFAMHWVRQAPGKGLEWVAVIWYDGSNKHYADSVKGRFTITRDNSKNTLNLQMNSLRAEDTAVYYCARAPRYDDDYEAFDVWGQGTMVTVSS,SYVLTQPPSVSVAPGQTARITCGGNNLGSKSVHWYQQKPGQAPVLVVYDDSDRPSWIPERFSGSNSGNTATLTISRGEAGDEADYYCQVWDSSSDHVVFGGGTKLTVL,112.00000000000009
TSLP,Tezepelumab,Inverse Folding,HCDR123,GFTFSTFA,IWYDGSNK,ARAPRYDEYWEAFDV,763.9999999999997,QMQLVESGGGVVQPGRSLRLSCAASGFTFSTFAMHWVRQAPGKGLEWVAVIWYDGSNKHYADSVKGRFTITRDNSKNTLNLQMNSLRAEDTAVYYCARAPRYDEYWEAFDVWGQGTMVTVSS,SYVLTQPPSVSVAPGQTARITCGGNNLGSKSVHWYQQKPGQAPVLVVYDDSDRPSWIPERFSGSNSGNTATLTISRGEAGDEADYYCQVWDSSSDHVVFGGGTKLTVL,763.9999999999997
TSLP,Tezepelumab,Inverse Folding,HCDR123,GFTFSTFA,IWYDGSNK,ARAPRYDDLYEAFDV,187.9999999999999,QMQLVESGGGVVQPGRSLRLSCAASGFTFSTFAMHWVRQAPGKGLEWVAVIWYDGSNKHYADSVKGRFTITRDNSKNTLNLQMNSLRAEDTAVYYCARAPRYDDLYEAFDVWGQGTMVTVSS,SYVLTQPPSVSVAPGQTARITCGGNNLGSKSVHWYQQKPGQAPVLVVYDDSDRPSWIPERFSGSNSGNTATLTISRGEAGDEADYYCQVWDSSSDHVVFGGGTKLTVL,187.9999999999999
TSLP,Tezepelumab,Inverse Folding,HCDR123,GFTFSTYA,IWYDGSNK,ARAPRYDEYYEAFDV,224.0000000000002,QMQLVESGGGVVQPGRSLRLSCAASGFTFSTYAMHWVRQAPGKGLEWVAVIWYDGSNKHYADSVKGRFTITRDNSKNTLNLQMNSLRAEDTAVYYCARAPRYDEYYEAFDVWGQGTMVTVSS,SYVLTQPPSVSVAPGQTARITCGGNNLGSKSVHWYQQKPGQAPVLVVYDDSDRPSWIPERFSGSNSGNTATLTISRGEAGDEADYYCQVWDSSSDHVVFGGGTKLTVL,224.0000000000002
TSLP,Tezepelumab,Inverse Folding,HCDR123,GFTFSTFA,IWYDGSNK,ARAPRYYDYWEAFDV,221.00000000000017,QMQLVESGGGVVQPGRSLRLSCAASGFTFSTFAMHWVRQAPGKGLEWVAVIWYDGSNKHYADSVKGRFTITRDNSKNTLNLQMNSLRAEDTAVYYCARAPRYYDYWEAFDVWGQGTMVTVSS,SYVLTQPPSVSVAPGQTARITCGGNNLGSKSVHWYQQKPGQAPVLVVYDDSDRPSWIPERFSGSNSGNTATLTISRGEAGDEADYYCQVWDSSSDHVVFGGGTKLTVL,221.00000000000017
TSLP,Tezepelumab,Inverse Folding,HCDR123,GFTFSTFA,IWYDGSNK,ARAPRYDDRYEAFDV,490.0000000000002,QMQLVESGGGVVQPGRSLRLSCAASGFTFSTFAMHWVRQAPGKGLEWVAVIWYDGSNKHYADSVKGRFTITRDNSKNTLNLQMNSLRAEDTAVYYCARAPRYDDRYEAFDVWGQGTMVTVSS,SYVLTQPPSVSVAPGQTARITCGGNNLGSKSVHWYQQKPGQAPVLVVYDDSDRPSWIPERFSGSNSGNTATLTISRGEAGDEADYYCQVWDSSSDHVVFGGGTKLTVL,490.0000000000002
TSLP,Tezepelumab,Inverse Folding,HCDR123,GFTFSTYA,IWYDGSNK,ARSPRYDEYYEAFDV,219.00000000000009,QMQLVESGGGVVQPGRSLRLSCAASGFTFSTYAMHWVRQAPGKGLEWVAVIWYDGSNKHYADSVKGRFTITRDNSKNTLNLQMNSLRAEDTAVYYCARSPRYDEYYEAFDVWGQGTMVTVSS,SYVLTQPPSVSVAPGQTARITCGGNNLGSKSVHWYQQKPGQAPVLVVYDDSDRPSWIPERFSGSNSGNTATLTISRGEAGDEADYYCQVWDSSSDHVVFGGGTKLTVL,219.00000000000009
TSLP,Tezepelumab,Inverse Folding,HCDR123,GFTFSTFA,IWYDGSNK,ARAPRYYYYYEAFDV,208.0000000000002,QMQLVESGGGVVQPGRSLRLSCAASGFTFSTFAMHWVRQAPGKGLEWVAVIWYDGSNKHYADSVKGRFTITRDNSKNTLNLQMNSLRAEDTAVYYCARAPRYYYYYEAFDVWGQGTMVTVSS,SYVLTQPPSVSVAPGQTARITCGGNNLGSKSVHWYQQKPGQAPVLVVYDDSDRPSWIPERFSGSNSGNTATLTISRGEAGDEADYYCQVWDSSSDHVVFGGGTKLTVL,208.0000000000002
TSLP,Tezepelumab,Inverse Folding,HCDR123,GFTFSTYA,IWYDGSNK,ARAPRYDEYVEAFDV,195.0000000000001,QMQLVESGGGVVQPGRSLRLSCAASGFTFSTYAMHWVRQAPGKGLEWVAVIWYDGSNKHYADSVKGRFTITRDNSKNTLNLQMNSLRAEDTAVYYCARAPRYDEYVEAFDVWGQGTMVTVSS,SYVLTQPPSVSVAPGQTARITCGGNNLGSKSVHWYQQKPGQAPVLVVYDDSDRPSWIPERFSGSNSGNTATLTISRGEAGDEADYYCQVWDSSSDHVVFGGGTKLTVL,195.0000000000001
TSLP,Tezepelumab,Inverse Folding,HCDR123,GFTFSSFA,IWYDGSNK,ARAPRYDEYYEAFDV,185.9999999999999,QMQLVESGGGVVQPGRSLRLSCAASGFTFSSFAMHWVRQAPGKGLEWVAVIWYDGSNKHYADSVKGRFTITRDNSKNTLNLQMNSLRAEDTAVYYCARAPRYDEYYEAFDVWGQGTMVTVSS,SYVLTQPPSVSVAPGQTARITCGGNNLGSKSVHWYQQKPGQAPVLVVYDDSDRPSWIPERFSGSNSGNTATLTISRGEAGDEADYYCQVWDSSSDHVVFGGGTKLTVL,185.9999999999999
TSLP,Tezepelumab,Inverse Folding,HCDR123,GFTFSTFA,IWYDGSNK,ARAPRYDWYLEAFDV,157.0000000000001,QMQLVESGGGVVQPGRSLRLSCAASGFTFSTFAMHWVRQAPGKGLEWVAVIWYDGSNKHYADSVKGRFTITRDNSKNTLNLQMNSLRAEDTAVYYCARAPRYDWYLEAFDVWGQGTMVTVSS,SYVLTQPPSVSVAPGQTARITCGGNNLGSKSVHWYQQKPGQAPVLVVYDDSDRPSWIPERFSGSNSGNTATLTISRGEAGDEADYYCQVWDSSSDHVVFGGGTKLTVL,157.0000000000001
TSLP,Tezepelumab,Inverse Folding,HCDR123,GFTFSTYA,IWYDGSNK,ARAPRYDDLYEAFDV,187.9999999999999,QMQLVESGGGVVQPGRSLRLSCAASGFTFSTYAMHWVRQAPGKGLEWVAVIWYDGSNKHYADSVKGRFTITRDNSKNTLNLQMNSLRAEDTAVYYCARAPRYDDLYEAFDVWGQGTMVTVSS,SYVLTQPPSVSVAPGQTARITCGGNNLGSKSVHWYQQKPGQAPVLVVYDDSDRPSWIPERFSGSNSGNTATLTISRGEAGDEADYYCQVWDSSSDHVVFGGGTKLTVL,187.9999999999999
TSLP,Tezepelumab,Inverse Folding,HCDR123,GFTFSTYA,IWYDGSNK,ARAPRYDEDYEAFDV,184.0000000000001,QMQLVESGGGVVQPGRSLRLSCAASGFTFSTYAMHWVRQAPGKGLEWVAVIWYDGSNKHYADSVKGRFTITRDNSKNTLNLQMNSLRAEDTAVYYCARAPRYDEDYEAFDVWGQGTMVTVSS,SYVLTQPPSVSVAPGQTARITCGGNNLGSKSVHWYQQKPGQAPVLVVYDDSDRPSWIPERFSGSNSGNTATLTISRGEAGDEADYYCQVWDSSSDHVVFGGGTKLTVL,184.0000000000001
TSLP,Tezepelumab,Inverse Folding,HCDR123,GFTFSTFA,IWYDGSNK,ARAPRYDEEYEAFDV,240.0000000000002,QMQLVESGGGVVQPGRSLRLSCAASGFTFSTFAMHWVRQAPGKGLEWVAVIWYDGSNKHYADSVKGRFTITRDNSKNTLNLQMNSLRAEDTAVYYCARAPRYDEEYEAFDVWGQGTMVTVSS,SYVLTQPPSVSVAPGQTARITCGGNNLGSKSVHWYQQKPGQAPVLVVYDDSDRPSWIPERFSGSNSGNTATLTISRGEAGDEADYYCQVWDSSSDHVVFGGGTKLTVL,240.0000000000002
TSLP,Tezepelumab,Inverse Folding,HCDR123,GFTFSTFA,IWYDGSNK,ARAPRYDDEYEAFDV,180.00000000000017,QMQLVESGGGVVQPGRSLRLSCAASGFTFSTFAMHWVRQAPGKGLEWVAVIWYDGSNKHYADSVKGRFTITRDNSKNTLNLQMNSLRAEDTAVYYCARAPRYDDEYEAFDVWGQGTMVTVSS,SYVLTQPPSVSVAPGQTARITCGGNNLGSKSVHWYQQKPGQAPVLVVYDDSDRPSWIPERFSGSNSGNTATLTISRGEAGDEADYYCQVWDSSSDHVVFGGGTKLTVL,180.00000000000017
TSLP,Tezepelumab,Inverse Folding,HCDR123,GFTFSTFA,IWYDGSNK,ARAPRYDDYLEAFDV,159.0000000000001,QMQLVESGGGVVQPGRSLRLSCAASGFTFSTFAMHWVRQAPGKGLEWVAVIWYDGSNKHYADSVKGRFTITRDNSKNTLNLQMNSLRAEDTAVYYCARAPRYDDYLEAFDVWGQGTMVTVSS,SYVLTQPPSVSVAPGQTARITCGGNNLGSKSVHWYQQKPGQAPVLVVYDDSDRPSWIPERFSGSNSGNTATLTISRGEAGDEADYYCQVWDSSSDHVVFGGGTKLTVL,159.0000000000001
TSLP,Tezepelumab,Inverse Folding,HCDR123,GFTFSTFA,IWYDGSNK,ARSPRYDDYYEAFDV,171.99999999999991,QMQLVESGGGVVQPGRSLRLSCAASGFTFSTFAMHWVRQAPGKGLEWVAVIWYDGSNKHYADSVKGRFTITRDNSKNTLNLQMNSLRAEDTAVYYCARSPRYDDYYEAFDVWGQGTMVTVSS,SYVLTQPPSVSVAPGQTARITCGGNNLGSKSVHWYQQKPGQAPVLVVYDDSDRPSWIPERFSGSNSGNTATLTISRGEAGDEADYYCQVWDSSSDHVVFGGGTKLTVL,171.99999999999991
TSLP,Tezepelumab,Inverse Folding,HCDR123,GFTFSTFA,IWYDGSNK,ARAPRYDEDYEAFDV,148.00000000000003,QMQLVESGGGVVQPGRSLRLSCAASGFTFSTFAMHWVRQAPGKGLEWVAVIWYDGSNKHYADSVKGRFTITRDNSKNTLNLQMNSLRAEDTAVYYCARAPRYDEDYEAFDVWGQGTMVTVSS,SYVLTQPPSVSVAPGQTARITCGGNNLGSKSVHWYQQKPGQAPVLVVYDDSDRPSWIPERFSGSNSGNTATLTISRGEAGDEADYYCQVWDSSSDHVVFGGGTKLTVL,148.00000000000003
TSLP,Tezepelumab,Inverse Folding,HCDR123,GFTFSTYA,IWYDGSNK,ARAPRYDDYLEAFDV,152.00000000000003,QMQLVESGGGVVQPGRSLRLSCAASGFTFSTYAMHWVRQAPGKGLEWVAVIWYDGSNKHYADSVKGRFTITRDNSKNTLNLQMNSLRAEDTAVYYCARAPRYDDYLEAFDVWGQGTMVTVSS,SYVLTQPPSVSVAPGQTARITCGGNNLGSKSVHWYQQKPGQAPVLVVYDDSDRPSWIPERFSGSNSGNTATLTISRGEAGDEADYYCQVWDSSSDHVVFGGGTKLTVL,152.00000000000003
TSLP,Tezepelumab,Inverse Folding,HCDR123,GFTFSSYA,IWYDGSNK,ARAPRYDDYYEAFDV,152.99999999999986,QMQLVESGGGVVQPGRSLRLSCAASGFTFSSYAMHWVRQAPGKGLEWVAVIWYDGSNKHYADSVKGRFTITRDNSKNTLNLQMNSLRAEDTAVYYCARAPRYDDYYEAFDVWGQGTMVTVSS,SYVLTQPPSVSVAPGQTARITCGGNNLGSKSVHWYQQKPGQAPVLVVYDDSDRPSWIPERFSGSNSGNTATLTISRGEAGDEADYYCQVWDSSSDHVVFGGGTKLTVL,152.99999999999986
TSLP,Tezepelumab,Inverse Folding,HCDR123,GFTFSTYA,IWYDGSNK,ARAPRYDYYWEAFDV,151.00000000000009,QMQLVESGGGVVQPGRSLRLSCAASGFTFSTYAMHWVRQAPGKGLEWVAVIWYDGSNKHYADSVKGRFTITRDNSKNTLNLQMNSLRAEDTAVYYCARAPRYDYYWEAFDVWGQGTMVTVSS,SYVLTQPPSVSVAPGQTARITCGGNNLGSKSVHWYQQKPGQAPVLVVYDDSDRPSWIPERFSGSNSGNTATLTISRGEAGDEADYYCQVWDSSSDHVVFGGGTKLTVL,151.00000000000009
TSLP,Tezepelumab,Inverse Folding,HCDR123,GFTFSSFA,IWYDGSNK,ARAPRYDDYYEAFDV,136.0000000000001,QMQLVESGGGVVQPGRSLRLSCAASGFTFSSFAMHWVRQAPGKGLEWVAVIWYDGSNKHYADSVKGRFTITRDNSKNTLNLQMNSLRAEDTAVYYCARAPRYDDYYEAFDVWGQGTMVTVSS,SYVLTQPPSVSVAPGQTARITCGGNNLGSKSVHWYQQKPGQAPVLVVYDDSDRPSWIPERFSGSNSGNTATLTISRGEAGDEADYYCQVWDSSSDHVVFGGGTKLTVL,136.0000000000001
TSLP,Tezepelumab,Inverse Folding,HCDR123,GFTFSTFA,IWYDGSNK,ARAPRYDEYVEAFDV,128.99999999999994,QMQLVESGGGVVQPGRSLRLSCAASGFTFSTFAMHWVRQAPGKGLEWVAVIWYDGSNKHYADSVKGRFTITRDNSKNTLNLQMNSLRAEDTAVYYCARAPRYDEYVEAFDVWGQGTMVTVSS,SYVLTQPPSVSVAPGQTARITCGGNNLGSKSVHWYQQKPGQAPVLVVYDDSDRPSWIPERFSGSNSGNTATLTISRGEAGDEADYYCQVWDSSSDHVVFGGGTKLTVL,128.99999999999994
TSLP,Tezepelumab,Inverse Folding,HCDR123,GFTFSTFA,IWYDGSNK,ARSPRYDEYWEAFDV,31.599999999999973,QMQLVESGGGVVQPGRSLRLSCAASGFTFSTFAMHWVRQAPGKGLEWVAVIWYDGSNKHYADSVKGRFTITRDNSKNTLNLQMNSLRAEDTAVYYCARSPRYDEYWEAFDVWGQGTMVTVSS,SYVLTQPPSVSVAPGQTARITCGGNNLGSKSVHWYQQKPGQAPVLVVYDDSDRPSWIPERFSGSNSGNTATLTISRGEAGDEADYYCQVWDSSSDHVVFGGGTKLTVL,31.599999999999973
TSLP,Tezepelumab,Inverse Folding,HCDR123,GFTFSTFA,IWYDGSNK,ARSPRYDWYYEAFDV,125.99999999999989,QMQLVESGGGVVQPGRSLRLSCAASGFTFSTFAMHWVRQAPGKGLEWVAVIWYDGSNKHYADSVKGRFTITRDNSKNTLNLQMNSLRAEDTAVYYCARSPRYDWYYEAFDVWGQGTMVTVSS,SYVLTQPPSVSVAPGQTARITCGGNNLGSKSVHWYQQKPGQAPVLVVYDDSDRPSWIPERFSGSNSGNTATLTISRGEAGDEADYYCQVWDSSSDHVVFGGGTKLTVL,125.99999999999989
TSLP,Tezepelumab,Inverse Folding,HCDR123,GFTFSTYA,IWYDGSNK,ARSPRYDWYYEAFDV,96.3000000000001,QMQLVESGGGVVQPGRSLRLSCAASGFTFSTYAMHWVRQAPGKGLEWVAVIWYDGSNKHYADSVKGRFTITRDNSKNTLNLQMNSLRAEDTAVYYCARSPRYDWYYEAFDVWGQGTMVTVSS,SYVLTQPPSVSVAPGQTARITCGGNNLGSKSVHWYQQKPGQAPVLVVYDDSDRPSWIPERFSGSNSGNTATLTISRGEAGDEADYYCQVWDSSSDHVVFGGGTKLTVL,96.3000000000001
TSLP,Tezepelumab,Inverse Folding,HCDR123,GFTFSTYA,IWYDGSNK,ARAPRYYYYYEAFDV,152.00000000000003,QMQLVESGGGVVQPGRSLRLSCAASGFTFSTYAMHWVRQAPGKGLEWVAVIWYDGSNKHYADSVKGRFTITRDNSKNTLNLQMNSLRAEDTAVYYCARAPRYYYYYEAFDVWGQGTMVTVSS,SYVLTQPPSVSVAPGQTARITCGGNNLGSKSVHWYQQKPGQAPVLVVYDDSDRPSWIPERFSGSNSGNTATLTISRGEAGDEADYYCQVWDSSSDHVVFGGGTKLTVL,152.00000000000003
TSLP,Tezepelumab,Inverse Folding,HCDR123,GFTFSTFA,IWYDGSNK,ARAPRYYEYWEAFDV,190.0,QMQLVESGGGVVQPGRSLRLSCAASGFTFSTFAMHWVRQAPGKGLEWVAVIWYDGSNKHYADSVKGRFTITRDNSKNTLNLQMNSLRAEDTAVYYCARAPRYYEYWEAFDVWGQGTMVTVSS,SYVLTQPPSVSVAPGQTARITCGGNNLGSKSVHWYQQKPGQAPVLVVYDDSDRPSWIPERFSGSNSGNTATLTISRGEAGDEADYYCQVWDSSSDHVVFGGGTKLTVL,190.0
TSLP,Tezepelumab,Inverse Folding,HCDR123,GFTFSTFA,IWYDGSNK,ARSPRYDEYLEAFDV,116.9999999999999,QMQLVESGGGVVQPGRSLRLSCAASGFTFSTFAMHWVRQAPGKGLEWVAVIWYDGSNKHYADSVKGRFTITRDNSKNTLNLQMNSLRAEDTAVYYCARSPRYDEYLEAFDVWGQGTMVTVSS,SYVLTQPPSVSVAPGQTARITCGGNNLGSKSVHWYQQKPGQAPVLVVYDDSDRPSWIPERFSGSNSGNTATLTISRGEAGDEADYYCQVWDSSSDHVVFGGGTKLTVL,116.9999999999999
TSLP,Tezepelumab,Inverse Folding,HCDR123,GFTFSTYA,IWYDGSNK,ARAPRYDDAYEAFDV,370.0,QMQLVESGGGVVQPGRSLRLSCAASGFTFSTYAMHWVRQAPGKGLEWVAVIWYDGSNKHYADSVKGRFTITRDNSKNTLNLQMNSLRAEDTAVYYCARAPRYDDAYEAFDVWGQGTMVTVSS,SYVLTQPPSVSVAPGQTARITCGGNNLGSKSVHWYQQKPGQAPVLVVYDDSDRPSWIPERFSGSNSGNTATLTISRGEAGDEADYYCQVWDSSSDHVVFGGGTKLTVL,370.0
TSLP,Tezepelumab,Inverse Folding,HCDR123,GFTFSTYA,IWYDGSNK,ARAPRYYEYWEAFDV,285.0,QMQLVESGGGVVQPGRSLRLSCAASGFTFSTYAMHWVRQAPGKGLEWVAVIWYDGSNKHYADSVKGRFTITRDNSKNTLNLQMNSLRAEDTAVYYCARAPRYYEYWEAFDVWGQGTMVTVSS,SYVLTQPPSVSVAPGQTARITCGGNNLGSKSVHWYQQKPGQAPVLVVYDDSDRPSWIPERFSGSNSGNTATLTISRGEAGDEADYYCQVWDSSSDHVVFGGGTKLTVL,285.0
TSLP,Tezepelumab,Inverse Folding,HCDR123,GFTFSTFA,IWYDGSNK,ARAPRYDDAYEAFDV,387.0,QMQLVESGGGVVQPGRSLRLSCAASGFTFSTFAMHWVRQAPGKGLEWVAVIWYDGSNKHYADSVKGRFTITRDNSKNTLNLQMNSLRAEDTAVYYCARAPRYDDAYEAFDVWGQGTMVTVSS,SYVLTQPPSVSVAPGQTARITCGGNNLGSKSVHWYQQKPGQAPVLVVYDDSDRPSWIPERFSGSNSGNTATLTISRGEAGDEADYYCQVWDSSSDHVVFGGGTKLTVL,387.0
TSLP,Tezepelumab,Inverse Folding,HCDR123,GFTFSTYA,IWYDGSNK,ARAPRYDYYYEAFDV,315.0000000000003,QMQLVESGGGVVQPGRSLRLSCAASGFTFSTYAMHWVRQAPGKGLEWVAVIWYDGSNKHYADSVKGRFTITRDNSKNTLNLQMNSLRAEDTAVYYCARAPRYDYYYEAFDVWGQGTMVTVSS,SYVLTQPPSVSVAPGQTARITCGGNNLGSKSVHWYQQKPGQAPVLVVYDDSDRPSWIPERFSGSNSGNTATLTISRGEAGDEADYYCQVWDSSSDHVVFGGGTKLTVL,315.0000000000003
TSLP,Tezepelumab,Inverse Folding,HCDR123,GFTFSTFA,IWYDGSNK,ARAPRYDWDYEAFDV,348.99999999999983,QMQLVESGGGVVQPGRSLRLSCAASGFTFSTFAMHWVRQAPGKGLEWVAVIWYDGSNKHYADSVKGRFTITRDNSKNTLNLQMNSLRAEDTAVYYCARAPRYDWDYEAFDVWGQGTMVTVSS,SYVLTQPPSVSVAPGQTARITCGGNNLGSKSVHWYQQKPGQAPVLVVYDDSDRPSWIPERFSGSNSGNTATLTISRGEAGDEADYYCQVWDSSSDHVVFGGGTKLTVL,348.99999999999983
TSLP,Tezepelumab,Inverse Folding,HCDR123,GFTFSTFA,IWYDGSNK,ARAPRYYWYWEAFDV,352.99999999999983,QMQLVESGGGVVQPGRSLRLSCAASGFTFSTFAMHWVRQAPGKGLEWVAVIWYDGSNKHYADSVKGRFTITRDNSKNTLNLQMNSLRAEDTAVYYCARAPRYYWYWEAFDVWGQGTMVTVSS,SYVLTQPPSVSVAPGQTARITCGGNNLGSKSVHWYQQKPGQAPVLVVYDDSDRPSWIPERFSGSNSGNTATLTISRGEAGDEADYYCQVWDSSSDHVVFGGGTKLTVL,352.99999999999983
TSLP,Tezepelumab,Inverse Folding,HCDR123,GFTFSTYA,IWYDGSNK,ARAPRYYEYYEAFDV,105.00000000000004,QMQLVESGGGVVQPGRSLRLSCAASGFTFSTYAMHWVRQAPGKGLEWVAVIWYDGSNKHYADSVKGRFTITRDNSKNTLNLQMNSLRAEDTAVYYCARAPRYYEYYEAFDVWGQGTMVTVSS,SYVLTQPPSVSVAPGQTARITCGGNNLGSKSVHWYQQKPGQAPVLVVYDDSDRPSWIPERFSGSNSGNTATLTISRGEAGDEADYYCQVWDSSSDHVVFGGGTKLTVL,105.00000000000004
TSLP,Tezepelumab,Inverse Folding,HCDR123,GFTFSTFA,IWYDGSNK,ARSPRYDDYWEAFDV,320.0000000000002,QMQLVESGGGVVQPGRSLRLSCAASGFTFSTFAMHWVRQAPGKGLEWVAVIWYDGSNKHYADSVKGRFTITRDNSKNTLNLQMNSLRAEDTAVYYCARSPRYDDYWEAFDVWGQGTMVTVSS,SYVLTQPPSVSVAPGQTARITCGGNNLGSKSVHWYQQKPGQAPVLVVYDDSDRPSWIPERFSGSNSGNTATLTISRGEAGDEADYYCQVWDSSSDHVVFGGGTKLTVL,320.0000000000002
TSLP,Tezepelumab,Inverse Folding,HCDR123,GFTFSTFA,IWYDGSNK,ARSPRYDEYYEAFDV,102.99999999999996,QMQLVESGGGVVQPGRSLRLSCAASGFTFSTFAMHWVRQAPGKGLEWVAVIWYDGSNKHYADSVKGRFTITRDNSKNTLNLQMNSLRAEDTAVYYCARSPRYDEYYEAFDVWGQGTMVTVSS,SYVLTQPPSVSVAPGQTARITCGGNNLGSKSVHWYQQKPGQAPVLVVYDDSDRPSWIPERFSGSNSGNTATLTISRGEAGDEADYYCQVWDSSSDHVVFGGGTKLTVL,102.99999999999996
TSLP,Tezepelumab,Inverse Folding,HCDR123,GFTFSTFA,IWYDGSNK,ARSPRYDYYYEAFDV,371.99999999999983,QMQLVESGGGVVQPGRSLRLSCAASGFTFSTFAMHWVRQAPGKGLEWVAVIWYDGSNKHYADSVKGRFTITRDNSKNTLNLQMNSLRAEDTAVYYCARSPRYDYYYEAFDVWGQGTMVTVSS,SYVLTQPPSVSVAPGQTARITCGGNNLGSKSVHWYQQKPGQAPVLVVYDDSDRPSWIPERFSGSNSGNTATLTISRGEAGDEADYYCQVWDSSSDHVVFGGGTKLTVL,371.99999999999983
TSLP,Tezepelumab,Inverse Folding,HCDR123,GFTFSTFA,IWYDGSNK,ARAPRYDYYLEAFDV,518.9999999999998,QMQLVESGGGVVQPGRSLRLSCAASGFTFSTFAMHWVRQAPGKGLEWVAVIWYDGSNKHYADSVKGRFTITRDNSKNTLNLQMNSLRAEDTAVYYCARAPRYDYYLEAFDVWGQGTMVTVSS,SYVLTQPPSVSVAPGQTARITCGGNNLGSKSVHWYQQKPGQAPVLVVYDDSDRPSWIPERFSGSNSGNTATLTISRGEAGDEADYYCQVWDSSSDHVVFGGGTKLTVL,518.9999999999998
TSLP,Tezepelumab,Inverse Folding,HCDR123,GFTFSTFA,IWYDGSNK,ARAPRYDEYLEAFDV,305.00000000000006,QMQLVESGGGVVQPGRSLRLSCAASGFTFSTFAMHWVRQAPGKGLEWVAVIWYDGSNKHYADSVKGRFTITRDNSKNTLNLQMNSLRAEDTAVYYCARAPRYDEYLEAFDVWGQGTMVTVSS,SYVLTQPPSVSVAPGQTARITCGGNNLGSKSVHWYQQKPGQAPVLVVYDDSDRPSWIPERFSGSNSGNTATLTISRGEAGDEADYYCQVWDSSSDHVVFGGGTKLTVL,305.00000000000006
TSLP,Tezepelumab,Inverse Folding,HCDR123,GFTFSTYA,IWYDGSNK,ARSPRYDYYYEAFDV,524.0000000000003,QMQLVESGGGVVQPGRSLRLSCAASGFTFSTYAMHWVRQAPGKGLEWVAVIWYDGSNKHYADSVKGRFTITRDNSKNTLNLQMNSLRAEDTAVYYCARSPRYDYYYEAFDVWGQGTMVTVSS,SYVLTQPPSVSVAPGQTARITCGGNNLGSKSVHWYQQKPGQAPVLVVYDDSDRPSWIPERFSGSNSGNTATLTISRGEAGDEADYYCQVWDSSSDHVVFGGGTKLTVL,524.0000000000003
TSLP,Tezepelumab,Inverse Folding,HCDR123,GFTFSTYA,IWYDGSNK,ARAPRYYDYWEAFDV,285.0,QMQLVESGGGVVQPGRSLRLSCAASGFTFSTYAMHWVRQAPGKGLEWVAVIWYDGSNKHYADSVKGRFTITRDNSKNTLNLQMNSLRAEDTAVYYCARAPRYYDYWEAFDVWGQGTMVTVSS,SYVLTQPPSVSVAPGQTARITCGGNNLGSKSVHWYQQKPGQAPVLVVYDDSDRPSWIPERFSGSNSGNTATLTISRGEAGDEADYYCQVWDSSSDHVVFGGGTKLTVL,285.0
TSLP,Tezepelumab,Inverse Folding,HCDR123,GFTFSTFA,IWYDGGNK,ARAPRYDEYYEAFDV,216.9999999999998,QMQLVESGGGVVQPGRSLRLSCAASGFTFSTFAMHWVRQAPGKGLEWVAVIWYDGGNKHYADSVKGRFTITRDNSKNTLNLQMNSLRAEDTAVYYCARAPRYDEYYEAFDVWGQGTMVTVSS,SYVLTQPPSVSVAPGQTARITCGGNNLGSKSVHWYQQKPGQAPVLVVYDDSDRPSWIPERFSGSNSGNTATLTISRGEAGDEADYYCQVWDSSSDHVVFGGGTKLTVL,216.9999999999998
TSLP,Tezepelumab,Inverse Folding,HCDR123,GFTFSTFA,IWYDGSNK,ARAPRYDEAYEAFDV,502.0000000000004,QMQLVESGGGVVQPGRSLRLSCAASGFTFSTFAMHWVRQAPGKGLEWVAVIWYDGSNKHYADSVKGRFTITRDNSKNTLNLQMNSLRAEDTAVYYCARAPRYDEAYEAFDVWGQGTMVTVSS,SYVLTQPPSVSVAPGQTARITCGGNNLGSKSVHWYQQKPGQAPVLVVYDDSDRPSWIPERFSGSNSGNTATLTISRGEAGDEADYYCQVWDSSSDHVVFGGGTKLTVL,502.0000000000004
